Delcath to Offer Data Highlighting Melphalan/HDS Trial at SSO Annual Meeting
March 27, 2015 at 08:40 AM EDT
Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on ...